Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLoans and Notes ReceivablesLong-Term Debt IssuancesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Northwest Biotherapeutics (NWBO) Shares Outstanding (2016 - 2025)

Historic Shares Outstanding for Northwest Biotherapeutics (NWBO) over the last 17 years, with Q3 2025 value amounting to $1.5 billion.

  • Northwest Biotherapeutics' Shares Outstanding rose 1804.0% to $1.5 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.5 billion, marking a year-over-year increase of 1804.0%. This contributed to the annual value of $1.3 billion for FY2024, which is 1303.01% up from last year.
  • As of Q3 2025, Northwest Biotherapeutics' Shares Outstanding stood at $1.5 billion, which was up 1804.0% from $1.5 billion recorded in Q2 2025.
  • Over the past 5 years, Northwest Biotherapeutics' Shares Outstanding peaked at $1.5 billion during Q3 2025, and registered a low of $842.4 million during Q1 2021.
  • Moreover, its 5-year median value for Shares Outstanding was $1.1 billion (2023), whereas its average is $1.1 billion.
  • Its Shares Outstanding has fluctuated over the past 5 years, first soared by 13108148.83% in 2021, then soared by 277.99% in 2022.
  • Over the past 5 years, Northwest Biotherapeutics' Shares Outstanding (Quarter) stood at $948.4 million in 2021, then increased by 12.65% to $1.1 billion in 2022, then grew by 10.02% to $1.2 billion in 2023, then increased by 13.03% to $1.3 billion in 2024, then increased by 14.28% to $1.5 billion in 2025.
  • Its Shares Outstanding stands at $1.5 billion for Q3 2025, versus $1.5 billion for Q2 2025 and $1.4 billion for Q1 2025.